Upstream Bio, Inc. Common Stock (UPB) Stock
NASDAQ · UPB
5.34
Fundamentals
Market cap
$292.48M
Price / Earnings ratio
-1.9x
Price / Sales ratio
92.1x
Price / Book ratio
1.1x
Return on assets
-0.4%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Upstream Bio, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees75
CEODr. E. Rand Sutherland M.D., M.P.H.
IPO DateOct 11, 2024
HeadquartersWaltham, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. E. Rand Sutherland M.D., M.P.H. | CEO & Director | 1970 |
| Mr. Michael Paul Gray CPA, MBA | CFO & COO | 1971 |
| Mr. Aaron Deykin M.D. | Chief Medical Officer and Head of Research & Development | 1967 |
| Ms. Stacy Price M.S., P.M.P. | Chief Technology Officer | 1969 |
| Meggan Buckwell | Director of Corporate Communications & Investor Relations | — |
| Ms. Allison C. Ambrose J.D. | Senior VP, General Counsel & Secretary | 1985 |
| Ms. Lisa Fiering | Senior Vice President of People & Culture | — |
| Dr. Adam Houghton M.B.A., Ph.D. | Chief Business Officer | 1971 |
| Ms. Mersedeh Miraliakbari Pharm.D. | Senior Vice President of Regulatory Affairs & Quality | — |
| Ms. Fang Xie Ph.D. | VP & Head of Biometrics | — |
Fundamentals
Valuation
Market cap$292.48M
Price-to-sales ratio92.08
Price-to-book value1.07
Price-earnings ratio-1.90
Return on Equity-44.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-2.89
Income Statement
Average volume588,066
EBITDA$-155.99M
1 year high (52w)$33.68
1 year low (52w)$5.24
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



